Human umbilical cord mesenchymal stem cell injection
/ Shanghai Life Science & Technology
- LARVOL DELTA
Home
Next
Prev
1 to 6
Of
6
Go to page
1
May 27, 2025
Human Umbilical Cord Mesenchymal Stem Cell Injection for the Treatment of Interstitial Lung Disease
(clinicaltrials.gov)
- P1 | N=24 | Not yet recruiting | Sponsor: Shanghai Life Science & Technology | Initiation date: Oct 2024 ➔ Oct 2025 | Trial primary completion date: Oct 2025 ➔ Oct 2027
Trial initiation date • Trial primary completion date • Interstitial Lung Disease • Pulmonary Disease • Respiratory Diseases
August 02, 2024
Human Umbilical Cord Mesenchymal Stem Cell Injection for the Treatment of Interstitial Lung Disease
(clinicaltrials.gov)
- P1 | N=24 | Not yet recruiting | Sponsor: Shanghai Life Science & Technology
New P1 trial • Interstitial Lung Disease • Pulmonary Disease • Respiratory Diseases
April 25, 2024
Phase I/IIa Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
(clinicaltrials.gov)
- P1 | N=18 | Recruiting | Sponsor: Shanghai Life Science & Technology | Phase classification: P1/2 ➔ P1 | Trial primary completion date: Aug 2023 ➔ Aug 2024
Phase classification • Trial primary completion date • Fibrosis • Idiopathic Pulmonary Fibrosis • Immunology • Pulmonary Disease • Respiratory Diseases • IL2 • IL6
October 26, 2022
Phase I/IIa Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
(clinicaltrials.gov)
- P1/2 | N=18 | Recruiting | Sponsor: Shanghai Life Science & Technology | Not yet recruiting ➔ Recruiting
Enrollment open • Fibrosis • Idiopathic Pulmonary Fibrosis • Immunology • Pulmonary Disease • Respiratory Diseases
August 12, 2022
Phase I/IIa Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
(clinicaltrials.gov)
- P1/2 | N=18 | Not yet recruiting | Sponsor: Shanghai Life Science & Technology | Phase classification: P1 ➔ P1/2
Phase classification • Fibrosis • Idiopathic Pulmonary Fibrosis • Immunology • Pulmonary Disease • Respiratory Diseases
July 21, 2022
Phase I Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
(clinicaltrials.gov)
- P1 | N=18 | Not yet recruiting | Sponsor: Shanghai Life Science & Technology
New P1 trial • Fibrosis • Idiopathic Pulmonary Fibrosis • Immunology • Pulmonary Disease • Respiratory Diseases
1 to 6
Of
6
Go to page
1